Odyssey raises more than $300M as biotech goes public
Odyssey Therapeutics pulled together $279 million from its initial public offering, the autoimmune disease drug developer said Thursday night. Odyssey began trading on the Nasdaq on Friday. The biotech sold 15.5 million shares {$ODTX} at ...
May 7, 2026 09:44 PM EDT FinancingStartupsIPOs Odyssey raises more than $300M as biotech goes public in IPO Kyle LaHucik Biotech Correspondent Odyssey Therapeutics pulled together $279 million from its initial public offering, the autoimmune disease drug developer said Thursday night. With its IPO now priced, Odyssey … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER
comments(0)
5-min edit window · permanent after that